CellaVision AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CEVI.ST research report →
Companywww.cellavision.com
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process.
- CEO
- Simon Ostergaard
- IPO
- 2007
- Employees
- 228
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $2.97B
- P/E
- 22.13
- P/S
- 4.06
- P/B
- 3.25
- EV/EBITDA
- 13.52
- Div Yield
- 2.21%
Profitability
- Gross Margin
- 67.98%
- Op Margin
- 23.74%
- Net Margin
- 18.35%
- ROE
- 15.43%
- ROIC
- 13.35%
Growth & Income
- Revenue
- $758.97M · 4.94%
- Net Income
- $153.08M · 8.78%
- EPS
- $6.42 · 8.81%
- Op Income
- $202.07M
- FCF YoY
- 50.57%
Performance & Tape
- 52W High
- $202.50
- 52W Low
- $117.60
- 50D MA
- $140.01
- 200D MA
- $157.81
- Beta
- 0.95
- Avg Volume
- 40.33K
Get TickerSpark's AI analysis on CEVI.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CEVI.ST Coverage
We haven't published any research on CEVI.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CEVI.ST Report →